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Abstract 
Objectives: Skin disorders are the most common health problems seen among HIV positive patients. It presents 
with a variety of manifestations which can cause significant morbidity. This study was aimed to assess the prevalence 
of common skin problems among children living with HIV/AIDS at Hawassa University Comprehensive Specialized 
Hospital, Hawassa, Ethiopia, 2017/2018. Hospital based cross-sectional study was conducted among 125 children 
living with HIV/AIDS who were recruited through simple random sampling techniques from February to April 2017. 
Pre-tested, structured questionnaires were used to collect the data.
Result: Among a total of 125 study participants, 72 (57.6%) of the children were males and 97 (77.6%) were in the 
age range of 10–14 years. 90 (72%) of participants had different kinds of skin problems. Among those who had one 
kind of common skin infection, 53 (42.4%) were males. Viral skin infections that accounts 48 (53.3%), were the leading 
cause of skin infections followed by 43 (47.8%), 33(36.7%) and 22 (24.7%) fungal infections, inflammatory and bacterial 
skin infections respectively. Among all children who were taking ART, only 2.4% of the children had skin related side 
effects.
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Introduction
HIV/AIDS is the most common and serious viral disease 
caused by human immunodeficiency virus (HIV) that 
affects about 39–46 million people in the world [1, 2]. 
Most reside in the developing world, with approximately 
two-third in sub-Saharan Africa and nearly 12% of these 
infections occurred in children younger than 15 years of 
age [3]. The USA and Europe have documented trans-
mission rates in untreated women between 12 and 30%. 
Transmission rates in Africa are higher that ranges from 
25 to 52% [4].
Skin infections account the most common clinical 
manifestations in children. About 90% of patients develop 
at least one type of skin disease during the course of their 
illness and more than one-third of patients present with 
skin lesions as a marker of HIV infection [5]. Skin and 
mucocutaneous infections such as herpes simplex infec-
tion, candidiasis, impetigo, ecthyma and furun-cles, mol-
lus-cum contagiosum, plane warts, seborrheic eczema 
and Kaposi’s sarco-ma etc. are common skin infections 
among people living with HIV/AIDS [2]. Skin disorders 
in children living with HIV/AIDS may have atypical pres-
entation, be inclined to be more severe and may diag-
nosed wrongly [6].
Children living with HIV can develop different infec-
tious and inflammatory diseases of the skin. These skin 
or mucocutaneous disorders may provide an early clue to 
the presence of pediatric HIV infection and often more 
severe and more difficult to treat than in the immune-
competent child. Skin disorders are common in children 
in Ethiopia, where nearly four out of five (72.6–79%) chil-
dren living with HIV/AIDS develop at least one skin type 
infection [6, 7].
Immune reconstruction induced by anti-retroviral 
therapy (ART) would be anticipated to decrease the 
prevalence of many opportunistic infections including 
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skin disorders due to inhibition of viral replication [8]. 
Hence, skin infections are major health problems among 
children living with HIV presenting with a variety of der-
matologic man-ifestations. In this study, our aim was to 




This descriptive cross-sectional study was conducted 
among children living with HIV/AIDS at Hawassa Uni-
versity comprehensive specialized hospital, ART clinic 
from February to April 2017. The sample size was calcu-
lated using a single population proportion formula was 
used to calculate required sample size. A total of 270 
children were registered in ART registry and actively tak-
ing ART drugs. Among those children who fulfilled the 
inclusion criteria, total of 125 children living with HIV/
AIDS were recruited using simple random sampling 
techniques by computer generated number using the 
ART registry number as sampling frame.
Data collection
Interviewer administered structured and pre-tested 
questionnaires were used to collect the data. The ques-
tionnaire had four parts such as socio demographic data 
of the child, socio demographic data of the care giver, 
ART Treatment related factors and skin problems in chil-
dren related questions. A standardized clinical history 
was documented and all participants undertake a com-
prehensive dermatologic examination by the dermatolo-
gists and expert nurse clinicians, as part of a full clinical 
evaluation including WHO staging. Clinical dermatologi-
cal evaluation was done in daylight and majority of the 
diagnoses of skin infections were done clinically. Labora-
tory tests that are appropriate to diagnose skin infections 
like KOH, gram stain, culture and sensitivity were done 
to affirm the diagnosis, when necessary.
Data analysis
Data were checked for completeness and consistency, 
then entered and cleaned using Epi-Data version 3.0. Sta-
tistical analysis was done using the Statistical Package for 
Social Sciences (SPSS) program version 20. Results were 




Among a total of 125 study participants, 72 (57.6%) of 
the children were males and 97 (77.6%) were in the age 
between 10 and 14 years. 91 (75.8%) of the children’s were 
attending primary education (grade 1–8) and majority 88 
(70.4%) of the children were fully immunized their vac-
cination (Table 1).
Socio‑demographic characteristics of the care takers
Out of 125 caretakers of children, 96 (76.8%) were female, 
65 (52%) were in age group 25–34 years, 114 (91.2%) were 
from urban residence, 42 (33.6%) and 38 (30.4%) of care-
takers were Amhara and Oromo by ethnicity, respectively 
(Table 2).
Prevalence of common skin infections
Out of all study participants, 90 (72%) had different kinds 
of skin problems. Of those patients who had at least one 
kinds of common skin infection, where 53 (42.4%) were 
males and 37 (29.6%) were females (Fig.  1). Among all 
study participants, majority 107 (85.6%) of the study par-
ticipants were currently on WHO clinical stage I and, 114 
(91.2%) of the children’s had been taken ART drugs for 
greater than or equal to 6 months. 70 (56%) of the study 
Table 1 Socio-demographic characteristics of the children living with HIV/AIDS in Hawassa Comprehensive Specialized 
Hospital, Hawassa, Ethiopia, 2018 (N = 125)
Variables Categories Number Percent (%)
Age 0–4 years 4 3.2
5–9 years 24 19.2
10–14 years 97 77.6
Sex Male 72 57.6
Female 53 42.4
Level of education (N = 121) Kindergarten education 4 3.3
Primary education 91 75.2
Secondary education 26 21.5
Immunization status Fully immunized 88 70.4
Immunized some 33 26.4
Non-immunized 4 3.2
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subjects were taken first line ART drug. Regarding drug 
adherence, 115 (92.0%) and 113 (90.4%) of the study par-
ticipants had drug dose and schedule adherence respec-
tively. Among all children who were taking ART, only 
2.4% of the children had skin related side effects. Viral 
skin infections which accounts 48 (53.3%) were the lead-
ing cause of skin infections followed by 43 (47.8%), 33 
(36.7%) and 22 (24.7%) fungal infections, inflammatory 
and bacterial skin infections, respectively (See Additional 
files 1, 2 and 3).
Table 2 Socio-demographic characteristics of  care taker of  children living with  HIV/AIDS in  Hawassa University 
Comprehensive Specialized Hospital, Hawassa, Ethiopia, 2018 (N = 125)
Variables Categories Number Percent (%)
Age 15–24 years 13 10.4
25–34 years 65 52.0
35–44 years 34 27.2
≥ 45 years 13 10.4
Sex Male 29 23.2
Female 96 76.8
Residence Urban 114 91.2
Rural 11 8.8













Family size 2–4 88 70.4
5–7 33 26.4
≥ 8 4 3.2
Level of education Illiterate 11 8.8
Read and write 27 21.6
Primary education completed 37 29.6
Secondary education completed 29 23.2
College/University completed 21 16.8
Occupation Merchant 22 17.6
Gov’t employee 28 22.4
Self-employee 39 31.2




Average monthly income > 1500 EBR 32 25.6
700–1499 EBR 60 48.0
< 700 EBR 27 21.6
Non specified 6 4.8
Family history of skin infection Yes 19 15.2
No 106 84.8
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Discussion
The aim of this study was to assess the pattern of skin 
problems among children living with HIV/AIDS attend-
ing in Hawassa University comprehensive specialized 
hospital, Hawassa, Ethiopia. Thus, skin and mucocutane-
ous infections can be the early indication of HIV-asso-
ciated compromised immune system [2, 9]. Therefore, 
identification of these HIV-related skin problems may 
possibly lead to early diagnosis of HIV infection and 
endowing with timely initiation of appropri-ate ART [2].
This study showed that 72% of children had at least 
one type of skin disorders. Similar to our study, high 
prevalence of skin and mucocutaneous infections has 
been reported in Addis Ababa, 72.6% and 79% [6, 7], in 
Cameroon (68.8%) [10], in Nigeria (72%) [11], and India 
(67.06%) [9]. Nevertheless, the finding lower than stud-
ies from Tanzania (85%) [12], Zimbabwe 88% [13] and, 
India 93.7% [14] and (88.3%) [15] and higher than a study 
conducted in Guinea (54.62%) [16]. The variations might 
be due to the occurrence and pattern of skin infections 
vary from region to region since specific skin manifesta-
tion are common in certain regions of the world [17]. In 
addition, differences in climatic and environmental cir-
cumstances [14], self-care and sanitation, and variation in 
sample size in the different studies may affect the varied 
results observed.
Viral skin infections which accounts for 53.3% were 
the leading cause of skin infections followed by fungal 
infections which accounts for 47.8% and inflammatory 
related skin infections (36.7%). This finding is in line 
with a study from India where viral, fungal and bacte-
rial skin infections took the highest prevalence [18]. The 
higher prevalence of these infectious dermatosis is due 
to the weakening of the Langerhan’s cells responsible for 
the mucocutaneous immunological system [19]. There 
has been a remarkable reduction in the opportunistic 
infections such as skin infections like oral candidiasis and 
seborrheic dermatosis with the introduction of Highly 
Activated Antiretroviral Therapy (HAART) [20]. How-
ever, some skin problems have paradoxically exacerbated 
after beginning of HAART like herpes zoster, mycobacte-
rium infections and drug reactions [21].
Infectious dermatosis is the most common cause of 
skin infections. Hence, in our study the most common 
infectious dermatosis was candidiasis (32.2%) and among 
non infectious dermatosis, pruritic papular eruption 
(PPE) (20%) accounts highest prevalence.
Conclusion
This study revealed that high prevalence of mucocuta-
neous disorder in HIV infected children. Most of the 
mucocutaneous disorders were secondary to infectious 
causes and drug related inflammatory condition. Chil-
dren with advanced immune-suppression are suffering 
from a wide spectrum of muco-cutaneous disorders. 
Thus, thorough evaluations of children are recommended 
in HIV care and treatment centers to address these 
problems.
Limitations of the study
The study conducted only descriptive part. Lacking 
detailed analysis on associated factors is the limitation of 
the study.
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